MWA Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Sell
254
-25
-9% -$25.5K 0.14% 107
2026
Q1
$258K Sell
279
-16
-5% -$16.2K 0.14% 107
2025
Q4
$315K Sell
295
-18
-6% -$17.2K 0.18% 100
2025
Q3
$237K Sell
313
-425
-58% -$316K 0.13% 118
2025
Q2
$574K Buy
738
+366
+98% +$284K 0.35% 73
2025
Q1
$307K Buy
372
+37
+11% +$30.8K 0.21% 102
2024
Q4
$259K Buy
335
+70
+26% +$58K 0.17% 113
2024
Q3
$235K Sell
265
-1
-0.4% -$899 0.16% 117
2024
Q2
$241K Sell
266
-1
-0.4% -$800 0.17% 112
2024
Q1
$208K Buy
+267
New +$190K 0.15% 119

Other funds holding LLY

MWA Asset Management's LLY Position: Q2 2026 in Review

MWA Asset Management reduced its Eli Lilly (LLY) stake by 9% in Q2 2026, selling an estimated $25.5K and leaving 254 shares worth $305K. The position accounts for 0.14% of the portfolio, ranked #107.

MWA Asset Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $574K in Q2 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MWA Asset Management held 254 shares of Eli Lilly worth $305K as of Q2 2026.
  • MWA Asset Management sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.14% of MWA Asset Management's portfolio in Q2 2026, its #107 holding.
  • MWA Asset Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • MWA Asset Management's Eli Lilly position peaked at $574K in Q2 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MWA Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.